Orthopedic Revenue Cycle Management

CMS has finalized a major change to Medicare joint replacement payment with the Comprehensive Care for Joint Replacement Expanded (CJR-X) Model. Under the FY 2027 Inpatient Prospective Payment System (IPPS) final rule, CJR-X will become a mandatory nationwide model beginning January 1, 2028, for most eligible acute care hospitals.

The model covers eligible Original Medicare patients receiving hip, knee, or ankle replacements in inpatient and hospital outpatient settings. Participating hospitals will be accountable for the cost and quality of an episode extending from the joint replacement procedure through 90 days after discharge. That episode can include services such as post-discharge physical therapy and follow-up care.

For orthopedic organizations, hospitals, surgeons, and rehabilitation providers, the change is more than a payment-policy update. It makes accurate documentation, claims management, utilization tracking, payment reconciliation, and coordination across the revenue cycle increasingly important.

What Is CJR-X?

CJR-X expands the earlier Comprehensive Care for Joint Replacement model nationwide. CMS describes it as a mandatory episode-based payment model designed to improve coordination and manage Medicare spending while maintaining quality.

Under CJR-X, the participating hospital is evaluated against a target price representing expected spending for an eligible lower-extremity joint replacement episode. The episode generally extends from the inpatient admission or outpatient procedure through 90 days after the patient leaves the hospital. Providers and suppliers continue to receive payment through existing Medicare payment systems, while CMS later compares total episode spending with the hospital’s target price and considers quality and spending performance.

Most hospitals paid under both IPPS and the Outpatient Prospective Payment System (OPPS) will be required to participate, subject to exclusions. Hospitals participating in TEAM, Maryland hospitals, and certain hospitals not paid under both IPPS and OPPS are among the exclusions identified by CMS.

Why CJR-X Matters to the Revenue Cycle

CJR-X changes the financial context surrounding joint replacement care. Individual providers will still submit claims through applicable Medicare payment systems, but participating hospitals will have a broader financial view of the entire episode.

That makes revenue cycle data more important than simply determining whether an individual claim was accepted.

An effective orthopedic RCM workflow should help organizations monitor:

Eligibility and Medicare coverage before services are delivered
Accurate diagnosis and procedure coding
Complete documentation supporting medical necessity
Claim submission and payment status
Denials, rejections, and corrected claims
Contractual reimbursement and potential underpayments
Accounts receivable aging
Post-acute and rehabilitation services associated with the episode
Payment trends and recurring claim-level issues

For hospitals and orthopedic organizations preparing for CJR-X, the objective is not simply to produce clean claims. It is to create reliable financial visibility across the services contributing to the joint replacement episode.

Physical Therapy and Post-Acute Care Become More Important

One of the most important implications of CJR-X is its 90-day episode structure.

CMS specifically identifies post-discharge services such as physical therapy as part of the broader episode of care. The model is intended to encourage coordination between hospitals, physicians, and post-acute providers throughout recovery.

For rehabilitation providers, this creates a stronger need for disciplined billing operations.

Physical therapy claims should be supported by accurate patient information, appropriate coding, complete documentation, and payer-specific requirements. Authorization and benefit verification should also be addressed when applicable to the patient’s coverage and services.

From an RCM perspective, unresolved therapy denials or delayed payments can create unnecessary financial friction even when the clinical service itself is appropriate.

Documentation and Data Will Matter

CJR-X includes five quality measures and a composite quality score that CMS will use when evaluating participating hospitals. The model also includes risk-adjustment policies designed to account for differences in patient complexity.

This reinforces the importance of accurate information flowing between clinical, administrative, and billing systems.

For revenue cycle teams, that means looking beyond claim submission. Documentation discrepancies, incomplete demographic information, coding inconsistencies, and missing supporting information can create downstream problems for billing and reporting.

A structured RCM process can help identify recurring issues before they become larger A/R or compliance problems.

FY 2027 IPPS Payment Update

CJR-X is only one component of the FY 2027 IPPS final rule.

CMS finalized a 2.3% update to IPPS payment rates for hospitals that meet applicable requirements, based on a 3.2% market basket increase reduced by a 0.9 percentage-point productivity adjustment.

That payment update should not be interpreted as a direct percentage increase for every orthopedic service or claim. Actual reimbursement remains dependent on applicable Medicare payment rules, case classification, patient circumstances, and other adjustments.

For RCM teams, this is another reason to monitor actual reimbursement rather than relying solely on expected payment amounts.

How Orthopedic Practices Can Prepare for CJR-X

Although CJR-X begins in 2028, preparation should start before implementation.

Orthopedic and hospital revenue cycle teams can use 2027 to:

Review joint replacement workflows. Identify where eligibility, coding, authorization, documentation, claims, payment posting, and A/R processes can break down.

Strengthen denial management. Track recurring denial reasons and determine whether problems originate in registration, coding, documentation, authorization, or claim submission.

Monitor reimbursement. Compare expected and actual payments and investigate recurring underpayments or unexplained payment variances.

Improve reporting. Develop reporting that gives management visibility into claims, A/R aging, denial trends, payment performance, and recurring payer issues.

Coordinate across care settings. Because CJR-X covers a 90-day episode, hospitals and participating organizations should improve communication with physicians and post-acute providers involved in patient recovery.

Read: Essential Orthopedic Billing & Coding Cheat Sheet

What CJR-X Means for RCM in 2027–2028

CJR-X moves joint replacement reimbursement further toward an episode-based approach in which cost, quality, and coordination are considered across a broader period of care.

For revenue cycle organizations, that means the traditional focus on individual claims needs to be supplemented with stronger reporting, payment reconciliation, denial prevention, documentation review, and A/R management.

CMS has finalized the model for January 1, 2028, giving eligible organizations time to review their workflows and establish the data and operational processes needed for the transition.

For orthopedic practices, hospitals, and rehabilitation organizations, the preparation opportunity is clear: understand how joint replacement services move through the revenue cycle today, identify financial leakage, and build processes that provide better visibility before CJR-X becomes operational.

Preparing for CJR-X? Contact CloudRCM Solutions to review your orthopedic billing, denial management, and A/R workflows.